Northern Trust Corp Has $11.73 Million Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Northern Trust Corp increased its stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 11.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,591,776 shares of the company's stock after purchasing an additional 166,731 shares during the period. Northern Trust Corp owned approximately 0.42% of LifeStance Health Group worth $11,731,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of LFST. Blue Trust Inc. grew its position in LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock valued at $27,000 after acquiring an additional 2,122 shares during the last quarter. R Squared Ltd bought a new position in LifeStance Health Group in the fourth quarter valued at about $80,000. Cibc World Markets Corp bought a new position in LifeStance Health Group in the fourth quarter valued at about $96,000. Forum Financial Management LP bought a new position in LifeStance Health Group in the fourth quarter valued at about $110,000. Finally, Handelsbanken Fonder AB bought a new position in LifeStance Health Group in the fourth quarter valued at about $128,000. Institutional investors own 85.50% of the company's stock.

LifeStance Health Group Trading Down 0.7%

Shares of LFST stock traded down $0.04 during mid-day trading on Thursday, reaching $5.63. 1,182,906 shares of the stock traded hands, compared to its average volume of 1,600,515. The stock's fifty day simple moving average is $6.44 and its two-hundred day simple moving average is $7.19. LifeStance Health Group, Inc. has a 1-year low of $4.64 and a 1-year high of $8.61. The company has a market cap of $2.19 billion, a price-to-earnings ratio of -21.65 and a beta of 1.30. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on LFST shares. Canaccord Genuity Group started coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 target price on the stock. KeyCorp started coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price on the stock. Finally, William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $8.30.

Insider Activity

In other news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the sale, the insider now directly owns 339,810 shares of the company's stock, valued at approximately $2,344,689. This trade represents a 5.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 3.20% of the company's stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.